The risk of type 2 oral polio vaccine use in post-cessation outbreak response

BACKGROUND: Wild type 2 poliovirus was last observed in 1999. The Sabin-strain oral polio vaccine type 2 (OPV2) was critical to eradication, but it is known to revert to a neurovirulent phenotype, causing vaccine-associated paralytic poliomyelitis. OPV2 is also transmissible and can establish circul...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Med
Autors principals: McCarthy, Kevin A., Chabot-Couture, Guillaume, Famulare, Michael, Lyons, Hil M., Mercer, Laina D.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5627419/
https://ncbi.nlm.nih.gov/pubmed/28974220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-017-0937-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars